NIKE, Inc. (NKE) Forms $67.59 Double Top; PROFOUND MED ORDINARY SHARES CANAD (PRFMF) Sellers Decreased By 40.62% Their Shorts

NIKE, Inc. (NYSE:NKE) Logo

NIKE, Inc. (NKE) formed double top with $70.29 target or 4.00% above today’s $67.59 share price. NIKE, Inc. (NKE) has $109.97 billion valuation. The stock increased 1.14% or $0.76 during the last trading session, reaching $67.59. About 756,499 shares traded. NIKE, Inc. (NYSE:NKE) has risen 18.31% since April 12, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.

PROFOUND MED CORP ORDINARY SHARES CANAD (OTCMKTS:PRFMF) had a decrease of 40.62% in short interest. PRFMF’s SI was 1,900 shares in April as released by FINRA. Its down 40.62% from 3,200 shares previously. With 15,900 avg volume, 0 days are for PROFOUND MED CORP ORDINARY SHARES CANAD (OTCMKTS:PRFMF)’s short sellers to cover PRFMF’s short positions. It closed at $0.766 lastly. It is down 0.00% since April 12, 2017 and is . It has underperformed by 11.55% the S&P500.

Profound Medical Corp., a medical device company, engages in developing and commercializing novel technologies to ablate the prostate gland in prostate cancer patients in Canada. The company has market cap of $76.92 million. It offers TULSA-PRO, a system for precise ablation of the prostate. It currently has negative earnings.

Among 44 analysts covering Nike Inc. (NYSE:NKE), 25 have Buy rating, 2 Sell and 17 Hold. Therefore 57% are positive. Nike Inc. has $156.0 highest and $42.0 lowest target. $71.59’s average target is 5.92% above currents $67.59 stock price. Nike Inc. had 232 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of NIKE, Inc. (NYSE:NKE) earned “Buy” rating by Citigroup on Tuesday, December 19. The firm earned “Buy” rating on Friday, March 23 by Deutsche Bank. On Wednesday, September 16 the stock rating was maintained by Deutsche Bank with “Buy”. The stock of NIKE, Inc. (NYSE:NKE) has “Equal-Weight” rating given on Wednesday, June 1 by Morgan Stanley. The firm has “Overweight” rating by Barclays Capital given on Wednesday, March 23. The firm earned “Hold” rating on Wednesday, June 29 by Canaccord Genuity. The company was maintained on Wednesday, March 23 by Goldman Sachs. As per Thursday, October 8, the company rating was upgraded by DA Davidson. As per Wednesday, December 28, the company rating was maintained by Credit Suisse. The rating was downgraded by Argus Research on Tuesday, April 4 to “Hold”.

Since December 11, 2017, it had 0 buys, and 8 sales for $45.81 million activity. PARKER MARK G sold $8.78 million worth of stock or 135,000 shares. 100,000 NIKE, Inc. (NYSE:NKE) shares with value of $6.77 million were sold by SPRUNK ERIC D. $6.85 million worth of NIKE, Inc. (NYSE:NKE) was sold by EDWARDS TREVOR A on Wednesday, January 31. 74,278 NIKE, Inc. (NYSE:NKE) shares with value of $4.75M were sold by Slusher John F. Another trade for 10,000 shares valued at $650,000 was made by Matheson Monique S. on Friday, December 15.

NIKE, Inc. (NYSE:NKE) Institutional Positions Chart